Premium
Improvement of blepharospasm with Zolpidem
Author(s) -
Garretto Nélida Susana,
Bueri José A.,
Rey Roberto D.,
Arakaki Tomoko,
Nano Gabriela V.,
Mancuso Marcela
Publication year - 2004
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.20085
Subject(s) - blepharospasm , zolpidem , basal ganglia , neuroscience , psychology , medicine , pharmacology , botulinum toxin , insomnia , central nervous system
Zolpidem (ZLP) is an imidazopyridine that binds to GABA receptors. We report on improvement of blepharospasm in 3 patients treated with ZLP. The GABAergic action of this drug on the output structures of the basal ganglia could explain the improvement of blepharospasm in these patients. © 2004 Movement Disorder Society
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom